Molina Healthcare, Inc $MOH Shares Sold by Legal & General Group Plc

Legal & General Group Plc trimmed its holdings in Molina Healthcare, Inc (NYSE:MOH) by 39.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 210,596 shares of the company’s stock after selling 139,635 shares during the period. Legal & General Group Plc’s holdings in Molina Healthcare were worth $36,547,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Swedbank AB boosted its stake in Molina Healthcare by 14.8% in the 4th quarter. Swedbank AB now owns 126,990 shares of the company’s stock worth $22,038,000 after buying an additional 16,398 shares during the last quarter. Catalyst Funds Management Pty Ltd acquired a new stake in Molina Healthcare in the 4th quarter worth about $1,562,000. Jefferies Financial Group Inc. boosted its stake in Molina Healthcare by 22.0% in the 4th quarter. Jefferies Financial Group Inc. now owns 12,913 shares of the company’s stock worth $2,241,000 after buying an additional 2,331 shares during the last quarter. Global Retirement Partners LLC boosted its stake in Molina Healthcare by 75.2% in the 4th quarter. Global Retirement Partners LLC now owns 410 shares of the company’s stock worth $71,000 after buying an additional 176 shares during the last quarter. Finally, Leonteq Securities AG acquired a new stake in Molina Healthcare in the 4th quarter worth about $216,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on MOH shares. The Goldman Sachs Group reduced their price objective on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 11th. Cantor Fitzgerald lifted their price objective on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Truist Financial lifted their price objective on Molina Healthcare from $180.00 to $205.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $129.00 price objective on shares of Molina Healthcare in a research note on Friday, April 24th. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Molina Healthcare currently has an average rating of “Hold” and an average target price of $178.53.

Molina Healthcare Stock Performance

NYSE MOH opened at $173.61 on Friday. The firm has a market capitalization of $9.05 billion, a P/E ratio of 51.36 and a beta of 0.85. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $311.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The business’s 50-day simple moving average is $163.77 and its 200-day simple moving average is $160.79.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company’s revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the company posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Activity at Molina Healthcare

In related news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.44% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.